To neutralize or not, a key HIV vaccine question

Nature Medicine

Volumn 17, Issue 10, 2011, Pages 1195-1197

  Hope, Thomas J ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOVIRUS VECTOR; HUMAN IMMUNODEFICIENCY VIRUS VACCINE; NEUTRALIZING ANTIBODY;

ANTIBODY RESPONSE; ARTICLE; CLINICAL TRIAL (TOPIC); CYTOTOXIC T LYMPHOCYTE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE RESPONSE; PRIORITY JOURNAL; VACCINATION; VIRUS NEUTRALIZATION; BIOLOGICAL MODEL; DISEASE TRANSMISSION; IMMUNOLOGY;

AIDS VACCINES; ANTIBODIES, NEUTRALIZING; CLINICAL TRIALS AS TOPIC; HIV INFECTIONS; HUMANS; MODELS, IMMUNOLOGICAL;

EID: 80053937149     PISSN: 10788956     EISSN: 1546170X     Source Type: Journal    
DOI: 10.1038/nm.2528     Document Type: Article

References (14)

1. Scheid, J.F. et al. Nature 458, 636-640 (2009).
2. Mikell, I. et al. PLoS Pathog. 7, e1001251 (2011).
3. Buchbinder, S.P. et al. Lancet 372, 1881-1893 (2008).
4. Rerks-Ngarm, S. et al. N. Engl. J. Med. 361, 2209-2220 (2009).
5. Emini, E.A. et al. Nature 355, 728-730 (1992).
6. Zhou, T. et al. Science 329, 811-817 (2010).
7. Simek, M.D. et al. J. Virol. 83, 7337-7348 (2009).
8. Walker, L. M. et al. Nature advance online publication doi:10.1038/nature10373 (17 August 2011).
9. Mouquet, H. et al. Nature 467, 591-595 (2010).
10. Scheid, J. F. et al. Science 333, 1630-1632 (2011).
11. Hessell, A.J. et al. Nature 449, 101-104 (2007).
12. Flynn, N.M. et al. J. Infect. Dis. 191, 654-665 (2005).
13. Kemp, T.J. et al. Vaccine 29, 2011-2014 (2011).
14. Plotkin, S.A. Clin. Vaccine Immunol. 17, 1055-1065 (2010).